---
title: "Julphar Swings to Preliminary Net Profit in FY24; Revenue Rise"
date: "2025-02-14 13:46:09"
summary: "Gulf Pharmaceutical Industries (ADX:JULPHAR), d/b/a Julphar, on Friday reported a preliminary net profit in 2024, while revenue from continuing operations jumped year over year. Net profit for the 12 months ended Dec. 31, 2024, was 40.5 million Emirati dirhams, compared with a net loss of 98.5 million dirhams earlier. EPS..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Gulf Pharmaceutical Industries (ADX:JULPHAR), d/b/a Julphar, on Friday reported a preliminary net profit in 2024, while revenue from continuing operations jumped year over year.

Net profit for the 12 months ended Dec. 31,Â 2024, was 40.5 million Emirati dirhams, compared with a net loss of 98.5 million dirhams earlier. EPS moved to 0.035 dirham from a loss per share of 0.086 dirham.

The pharmaceutical company's revenue from continuing operations was 1.31 billion dirhams, compared with 1.28 billion dirhams previously.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250214:G2467812:0/)
